tiprankstipranks
Advertisement
Advertisement

RVMD Stock Latest News

Erasca price target raised to $9 from $2 at BofA
The FlyErasca price target raised to $9 from $2 at BofA
2d ago
ERAS
RVMD
Erasca believes Revolution infringement claims ‘without merit,’ says Stifel
PremiumThe Fly
Erasca believes Revolution infringement claims ‘without merit,’ says Stifel
3d ago
ERAS
RVMD
Erasca sinks after Revolution Medicines alleges patent infringement
PremiumThe Fly
Erasca sinks after Revolution Medicines alleges patent infringement
3d ago
ERAS
RVMD
Revolution Medicines: Daraxonrasib Data De‑Risk Pivotal Pancreatic Cancer Program, Supporting Buy Rating and $169 Target
PremiumRatings
Revolution Medicines: Daraxonrasib Data De‑Risk Pivotal Pancreatic Cancer Program, Supporting Buy Rating and $169 Target
8d ago
RVMD
Buy Rating on RVMD Driven by Promising Pancreatic Cancer Data and Next‑Generation RAS Franchise Potential
PremiumRatings
Buy Rating on RVMD Driven by Promising Pancreatic Cancer Data and Next‑Generation RAS Franchise Potential
8d ago
RVMD
Revolution Medicines: Strong Zoldonrasib Efficacy and Strengthened Balance Sheet Support Buy Rating and Higher Target
PremiumRatingsRevolution Medicines: Strong Zoldonrasib Efficacy and Strengthened Balance Sheet Support Buy Rating and Higher Target
10d ago
RVMD
Revolution Medicines to present updated Phase 1 data for zoldonrasib
Premium
The Fly
Revolution Medicines to present updated Phase 1 data for zoldonrasib
11d ago
RVMD
Revolution Medicines Raises $500 Million via Convertible Notes
Premium
Company Announcements
Revolution Medicines Raises $500 Million via Convertible Notes
13d ago
8K
RVMD
Revolution Medicines Raises Capital via Equity and Convertible Notes
PremiumCompany Announcements
Revolution Medicines Raises Capital via Equity and Convertible Notes
14d ago
8K
RVMD
3 Best Trending Stocks, According to Analysts – 4/16/2026
PremiumMarket News
3 Best Trending Stocks, According to Analysts – 4/16/2026
14d ago
AMZN
GSAT
Revolution Medicines 10.563M share Secondary priced at $142.00
PremiumThe Fly
Revolution Medicines 10.563M share Secondary priced at $142.00
15d ago
RVMD
Revolution Medicines price target raised to $200 from $140 at Evercore ISI
PremiumThe Fly
Revolution Medicines price target raised to $200 from $140 at Evercore ISI
16d ago
RVMD
Revolution Medicines price target raised to $175 from $160 at Guggenheim
PremiumThe FlyRevolution Medicines price target raised to $175 from $160 at Guggenheim
16d ago
RVMD
Revolution Medicines price target raised to $162 from $140 at RBC Capital
Premium
The Fly
Revolution Medicines price target raised to $162 from $140 at RBC Capital
16d ago
RVMD
Revolution Medicines price target raised to $169 from $73 at H.C. Wainwright
Premium
The Fly
Revolution Medicines price target raised to $169 from $73 at H.C. Wainwright
16d ago
RVMD
Revolution Medicines files to sell $750M of common stock
PremiumThe Fly
Revolution Medicines files to sell $750M of common stock
17d ago
RVMD
Revolution Medicines files to sell $250M of convertible senior notes
PremiumThe Fly
Revolution Medicines files to sell $250M of convertible senior notes
17d ago
RVMD
Morning News Wrap-Up 4/13/26: Today’s Biggest Stock Market Stories!
PremiumMarket News
Morning News Wrap-Up 4/13/26: Today’s Biggest Stock Market Stories!
17d ago
GS
HD
Bar remains unchanged for Erasca after Revolution’s ‘clear win,’ says Jefferies
PremiumThe Fly
Bar remains unchanged for Erasca after Revolution’s ‘clear win,’ says Jefferies
17d ago
ERAS
RVMD
Erasca drops 9% to $15.54 after Revolution pancreatic cancer data
PremiumThe FlyErasca drops 9% to $15.54 after Revolution pancreatic cancer data
17d ago
ERAS
RVMD
Midday Fly By: Goldman reports Q1 beat, Baker Hughes to sell Waygate
Premium
The Fly
Midday Fly By: Goldman reports Q1 beat, Baker Hughes to sell Waygate
17d ago
GS
BBY
Revolution Medicines rises 37.9%
Premium
The Fly
Revolution Medicines rises 37.9%
17d ago
RVMD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >